Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 14, 2017
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
Wed, September 13, 2017
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
Jeffrey Silber Maintained (BIIB) at Hold with Increased Target to $377 on, Sep 13th, 2017
Jeffrey Silber of BMO Capital, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $328 to $377 on, Sep 13th, 2017.
Jeffrey has made no other calls on BIIB in the last 4 months.
There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 3 agree with Jeffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "UBS" Maintained at Hold with Increased Target to $285 on, Wednesday, July 26th, 2017
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $311 on, Wednesday, July 26th, 2017
- Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017
These are the ratings of the 2 analyists that currently disagree with Jeffrey
- Terence Flynn of "Goldman Sachs" Upgraded at Strong Buy on, Wednesday, August 16th, 2017
- Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017
